BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 25636338)

  • 1. The biology and treatment of plasmablastic lymphoma.
    Castillo JJ; Bibas M; Miranda RN
    Blood; 2015 Apr; 125(15):2323-30. PubMed ID: 25636338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options.
    Castillo JJ; Chavez JC; Hernandez-Ilizaliturri FJ; Montes-Moreno S
    Expert Rev Hematol; 2015 Jun; 8(3):343-54. PubMed ID: 25641215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmablastic lymphoma: current knowledge and future directions.
    Li JW; Peng HL; Zhou XY; Wang JJ
    Front Immunol; 2024; 15():1354604. PubMed ID: 38415257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmablastic lymphoma: a systematic review.
    Castillo JJ; Reagan JL
    ScientificWorldJournal; 2011 Mar; 11():687-96. PubMed ID: 21442146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmablastic lymphoma of the retroperitoneum in an HIV- and HCV-positive patient: hard to diagnose and harder to treat.
    Dholaria B; Alapat D; Pandey T; Agarwal A
    Med Oncol; 2012 Dec; 29(5):3529-34. PubMed ID: 22562157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
    Morley AM; Verity DH; Meligonis G; Rose GE
    Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
    Castillo JJ; Reagan JL; Sikov WM; Winer ES
    Br J Haematol; 2015 May; 169(3):352-5. PubMed ID: 25612847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive plasmablastic lymphoma of the thoracic spine presenting as acute spinal cord compression in a case of asymptomatic undiagnosed human immunodeficiency virus infection.
    Harris E; Butler JS; Cassidy N
    Spine J; 2014 Jul; 14(7):e1-5. PubMed ID: 24362000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib-induced tumor lysis syndrome in a patient with HIV-negative plasmablastic lymphoma.
    Lipstein M; O'Connor O; Montanari F; Paoluzzi L; Bongero D; Bhagat G
    Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):E43-6. PubMed ID: 21856550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics.
    Hansra D; Montague N; Stefanovic A; Akunyili I; Harzand A; Natkunam Y; de la Ossa M; Byrne GE; Lossos IS
    Am J Clin Pathol; 2010 Nov; 134(5):710-9. PubMed ID: 20959653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1-Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Prognostic Factors, and Special Populations.
    Bibas M
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024007. PubMed ID: 38223486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmablastic lymphoma of the stomach: an unusual presentation.
    Riaz H; Zaiden R; Khan M; Latif N
    Clin Adv Hematol Oncol; 2012 Jul; 10(7):477-80. PubMed ID: 22895293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.
    Castillo JJ; Winer ES; Stachurski D; Perez K; Jabbour M; Milani C; Colvin G; Butera JN
    Leuk Lymphoma; 2010 Nov; 51(11):2047-53. PubMed ID: 20919850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasmablastic lymphoma].
    Fernández-Álvarez R; Sancho JM; Ribera JM
    Med Clin (Barc); 2016 Nov; 147(9):399-404. PubMed ID: 27576534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmablastic lymphoma: current perspectives.
    Lopez A; Abrisqueta P
    Blood Lymphat Cancer; 2018; 8():63-70. PubMed ID: 31360094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic features of plasmablastic lymphoma: Single-center series of 8 cases from Saudi Arabia.
    Elyamany G; Alzahrani AM; Aljuboury M; Mogadem N; Rehan N; Alsuhaibani O; Alabdulaaly A; Al-Mussaed E; Elhag I; AlFiaar A
    Diagn Pathol; 2015 Jun; 10():78. PubMed ID: 26108914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric plasmablastic lymphoma: a clinicopathologic study.
    Vaubell JI; Sing Y; Ramburan A; Sewram V; Thejpal R; Rapiti N; Ramdial PK
    Int J Surg Pathol; 2014 Oct; 22(7):607-16. PubMed ID: 24771257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral plasmablastic lymphoma: A case report.
    Zizzo M; Zanelli M; Martiniani R; Sanguedolce F; De Marco L; Martino G; Parente P; Annessi V; Manzini L; Ascani S
    Medicine (Baltimore); 2020 Sep; 99(39):e22335. PubMed ID: 32991445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmablastic Lymphoma Presenting as Extensive Peritoneal and Retroperitoneal Nodules in an HIV-Positive Patient.
    Pokhrel A; Yuldasheva O; Mirashi E; Nair K; Salyana M; Jaswani V; Avezbakiyev B; Wang JC
    J Investig Med High Impact Case Rep; 2022; 10():23247096211065633. PubMed ID: 35073776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis.
    Harmon CM; Smith LB
    Arch Pathol Lab Med; 2016 Oct; 140(10):1074-8. PubMed ID: 27684979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.